Birindelli, G.; Drobnjakovic, M.; Morath, V.; Steiger, K.; D’Alessandria, C.; Gourni, E.; Afshar-Oromieh, A.; Weber, W.; Rominger, A.; Eiber, M.;
et al. Is Hypoxia a Factor Influencing PSMA-Directed Radioligand Therapy?—An In Silico Study on the Role of Chronic Hypoxia in Prostate Cancer. Cancers 2021, 13, 3429.
https://doi.org/10.3390/cancers13143429
AMA Style
Birindelli G, Drobnjakovic M, Morath V, Steiger K, D’Alessandria C, Gourni E, Afshar-Oromieh A, Weber W, Rominger A, Eiber M,
et al. Is Hypoxia a Factor Influencing PSMA-Directed Radioligand Therapy?—An In Silico Study on the Role of Chronic Hypoxia in Prostate Cancer. Cancers. 2021; 13(14):3429.
https://doi.org/10.3390/cancers13143429
Chicago/Turabian Style
Birindelli, Gabriele, Milos Drobnjakovic, Volker Morath, Katja Steiger, Calogero D’Alessandria, Eleni Gourni, Ali Afshar-Oromieh, Wolfgang Weber, Axel Rominger, Matthias Eiber,
and et al. 2021. "Is Hypoxia a Factor Influencing PSMA-Directed Radioligand Therapy?—An In Silico Study on the Role of Chronic Hypoxia in Prostate Cancer" Cancers 13, no. 14: 3429.
https://doi.org/10.3390/cancers13143429
APA Style
Birindelli, G., Drobnjakovic, M., Morath, V., Steiger, K., D’Alessandria, C., Gourni, E., Afshar-Oromieh, A., Weber, W., Rominger, A., Eiber, M., & Shi, K.
(2021). Is Hypoxia a Factor Influencing PSMA-Directed Radioligand Therapy?—An In Silico Study on the Role of Chronic Hypoxia in Prostate Cancer. Cancers, 13(14), 3429.
https://doi.org/10.3390/cancers13143429
